Donor treatment with phentolamine mesylate improves machine preservation dynamics and early renal allograft function

Transplantation

Volumn 69, Issue 1, 2000, Pages 184-186

  Polyak, Maximilian M R ^a,b   O'Mar Arrington, Ben ^a   Kapur, Sandip ^a,b   Stubenbord, William T ^a,b   Kinkhabwala, Milan ^a,b,c  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDRALAZINE; PHENTOLAMINE MESYLATE;

ARTICLE; CRYOPRESERVATION; FUNCTIONAL ASSESSMENT; HUMAN; KIDNEY ALLOGRAFT; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0034650534     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200001150-00033     Document Type: Article

References (7)

1. Pratschke J, Wilhelm MJ, Kusaka M, et al. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 1999; 67: 343.
2. Takada M, Nadeau KC, Chandraker A, et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Surg Forum 1998; 49: 64.
3. Paul LC, Valentin JF, Bruijn JA, Zhang S. Donor treatment with mycophenlate mofetil protects against ischemia-reperfusion injury. Transplant Proc 1999; 31: 1026.
4. Naka Y, Chowdhury C, Liao H, et al. Enhanced preservation of orthotopically transplanted rat lungs by nitroglycerin but not hydralazine. Circulation Res 1995; 76: 900.
5. Hinterberger JW, Kintzi HE. Phentolamine reversal of epinephrine-induced digital vasospasm. Arch Fam Med 1994; 3: 193.
6. Northover BJ. A comparison of the electrophysiological actions of phentolamine with those of some other antiarrhythmic drugs on tissues isolated from the rat heart. Br J Pharmacol 1983; 80: 85.
7. Frelin C, Vigne P, Lazdunski M. Biochemical evidence for pharmacological similarities between a-adrenoceptors and voltagedependent Na+ and Ca++ channels. Biochem Biophys Res Commun 1982; 106: 967.